Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharm

firstwordpharmaAugust 16, 2021

Tag: SEC , Cellect Biotechnology , Quoin Pharmaceuticals

PharmaSources Customer Service